|
- Version 10 February 2012 - Geneesmiddeleninformatiebank
Based on the review of the quality, safety and efficacy data, the Member States have granted a marketing authorisation for Paracetamol Baxter 10 mg ml, solution for infusion, from Baxter B V
- Paracetamol (IV formulation): List of nationally authorised medicinal . . .
List of nationally authorised medicinal products Active substance: paracetamol (IV formulation)
- PARACETAMOL-AFT SOLUTION FOR INFUSION 10MG ML - HSA Approval | MedPath
View PARACETAMOL-AFT SOLUTION FOR INFUSION 10MG ML HSA approval details, including approval number, regulatory information, formulation details and more
- Paracetamol Infusion BP 2025 - British Pharmacopoeia
cetamol Infusion – BP 2025 These chromatograms are provided for information only as an aid to analysts and are intended as guidance for the interpretation and pplication of BP monographs Typical chromatogram for solution (5) from the Related Substances test for Paracetamol Infu
- Paracetamol 10 mg ml Solution for Infusion - hpra. ie
For hospital use only Parametric Release for Sterility approved on 14th March 2014 in accordance with CPMP QWP 3015 99, Note for guidance on Parametric Release and Annex 17 to the EU guide on Good Manufacturing Practice provided the following conditions a
- PARACETAMOL BAXTER Solution for infusion - RxReasoner
Paracetamol can be diluted in a 0 9% sodium chloride solution or 5% glucose solution up to one tenth (one volume Paracetamol into nine volumes diluent) The diluted solution should be visually inspected and should not be used in presence of opalescence, visible particulate matters or precipitate
- MHRA Products | Product results
I understand that the MHRA has used its best endeavours in publishing this information, but accept that the information may not be the most up to date version for this product To view details for
- (Approval lapsed) Paracetamol S. A. L. F. 10mg mL (1000mg 100mL) solution . . .
Paracetamol 10 mg mL solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary
|
|
|